Portal de investigação
TERTmonitor-qPCR Detection of TERTp Mutations in Glioma
Data de publicação:
Autores da FMUP
Participantes de fora da FMUP
- Brás, JP
- Jesus, TT
- Prazeres, H
- Lima, J
- Vinagre, J
Unidades de investigação
Abstract
Telomerase promoter (TERTp) mutations are frequently observed in various types of tumours and commonly characterised by two specific hotspots located at positions -124 and -146 upstream of the start codon. They enhance TERTp activity, resulting in increased TERT expression. In central nervous system (CNS) tumours, they are integrated as biomarkers, aiding in the diagnosis and with a role in prognosis, where, in some settings, they are associated with aggressive behaviour. In this study, we evaluated the performance of TERTmonitor for TERTp genotyping in a series of 185 gliomas in comparison to the traditional method, Sanger sequencing. Against the gold-standard Sanger method, TERTmonitor performed with a 97.8% accuracy. Inaccuracy was mainly due to the over-detection of variants in negative cases (by Sanger) and the presence of variants that can modify the chemistry of the probe detection. The distribution of the mutations was comparable to other series, with the -124 being the most represented (38.92% for Sanger and TERTmonitor) and more prevalent in the higher-grade tumours, gliosarcoma (50.00%) and glioblastoma (52.6%). The non-matched cases are debatable, as we may be dealing with the reduced sensitivity of Sanger in detecting rare alleles, which strengthens the use of the TERTmonitor. With this study, we present a reliable and rapid potential tool for TERTp genotyping in gliomas.
Dados da publicação
- ISSN/ISSNe:
- 2073-4425, 2073-4425
- Tipo:
- Article
- Páginas:
- 1693-
- Link para outro recurso:
- www.scopus.com
Genes Multidisciplinary Digital Publishing Institute (MDPI)
Citações Recebidas na Scopus: 2
Documentos
- Não há documentos
Filiações
Keywords
- telomerase promoter; qPCR; genotyping; gliomas; CNS tumours; TERTmonitor
Campos de estudo
Financiamento
Proyectos asociados
Selenium Clinical Supplementation In Autoimmune Thyroid Disease: A Portuguese Survey
Investigador Principal: Ana Paula Soares Dias Ferreira
Estudo Clínico Académico . 2022
Squamous cell carcinogenesis of the skin: Molecular characterization of prognostic therapeutic biomakers
Investigador Principal: Ana Paula Soares Dias Ferreira
Estudo Clínico Académico . 2022
Clinicopathological features and molecular biomarkers? role predicting papillary thyroid cancer patients? outcome: How to personalize and guide surgical treatment
Investigador Principal: Ana Paula Soares Dias Ferreira
Estudo Clínico Académico . 2022
Fatores do microambiente tumoral no cancro do ovário.
Investigador Principal: Ana Paula Soares Dias Ferreira
Estudo Clínico Académico . 2022
Citar a publicação
Brás JP,Jesus TT,Prazeres H,Lima J,Soares Dias Ferreira A,Vinagre J. TERTmonitor-qPCR Detection of <i>TERTp</i> Mutations in Glioma. Genes. 2023. 14. (9):p. 1693-1693. IF:3,500. (2).
